• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


What does Raymond Debanne thinks?

anonymous

Guest
He and his Belgium partner are invested in this company for quite some time. What does he think? Why did he hang on to Coats and Wade so long? He must be dissapointed?!